Cargando…
B-cell lymphoma 2 family members and sarcomas: a promising target in a heterogeneous disease
Targeting the B-cell lymphoma 2 (Bcl-2) family proteins has been the backbone for hematological malignancies with overall survival improvements. The Bcl-2 family is a major player in apoptosis regulation and, has captured the researcher’s interest in the treatment of solid tumors. Sarcomas are a het...
Autores principales: | Oliveira, Rui Caetano, Gama, João, Casanova, José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Exploration Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501895/ https://www.ncbi.nlm.nih.gov/pubmed/37720343 http://dx.doi.org/10.37349/etat.2023.00154 |
Ejemplares similares
-
B7 Family Members in Lymphoma: Promising Novel Targets for Tumor Immunotherapy?
por: Zhang, Wei, et al.
Publicado: (2021) -
Role of B7 family members in glioma: Promising new targets for tumor immunotherapy
por: Wang, Yan, et al.
Publicado: (2023) -
Galectin Family Members: Emerging Novel Targets for Lymphoma Therapy?
por: Shi, Yuanwei, et al.
Publicado: (2022) -
Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma
por: de Jong, Yvonne, et al.
Publicado: (2018) -
Identification of Kinesin Family Member 2A (KIF2A) as a Promising Therapeutic Target for Osteosarcoma
por: Wang, Zhe-Xiang, et al.
Publicado: (2020)